Showing results (101-110 of 285) with videos related to

Sort By:
Pageof 29
Blood|March 22, 2003
A 6-month versus a 12-month surveillance for hepatocellular carcinoma in 559 hemophiliacs infected with the hepatitis C virusElena Santagostino, Massimo Colombo, Monica Rivi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 22, 2017
IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patientsEnrico Galmozzi, Floriana Facchetti, Glenda Grossi, et al.
Cancer|July 25, 2003
The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinomaMassimo Iavarone, Pietro Lampertico, Chiara Seletti, et al.
Antiviral Therapy|November 21, 2007
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre studyMaria Grazia Rumi, Alessio Aghemo, Roberta D'Ambrosio, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2022
Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbookAriel Jaffe, Tamar H Taddei, Edoardo G Giannini, et al.
Antiviral Therapy|February 2, 2012
Cytoplasmic rods and rings autoantibodies developed during pegylated interferon and ribavirin therapy in patients with chronic hepatitis CGiovanni Covini, Wendy C Carcamo, Elena Bredi, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 14, 2011
Long-term add-on therapy with adefovir in lamivudine-resistant kidney graft recipients with chronic hepatitis BPietro Lampertico, Mauro Viganò, Floriana Facchetti, et al.
Carbohydrate Polymers|June 5, 2016
Mechanically flexible and optically transparent three-dimensional nanofibrous amorphous aerocelluloseFarouk Ayadi, Beatriz Martín-García, Massimo Colombo, et al.
Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.
The American Journal of Gastroenterology|August 28, 2004
Serum levels of hepatitis C virus core antigen as a marker of infection and response to therapyRoberta Soffredini, Maria Grazia Rumi, Maria Luisa Parravicini, et al.
Pageof 29